Omnicell, Inc. (Omnicell) is a leader in transforming the pharmacy and nursing care delivery model.
The company is committed to solving the critical challenges inherent in medication management and elevating the role of clinicians within healthcare as an essential component of care delivery.
The company’s major products and related services are medication management solutions and adherence tools for healthcare systems and pharmacies, which are sold in its principal market, the healthcare indus...
Omnicell, Inc. (Omnicell) is a leader in transforming the pharmacy and nursing care delivery model.
The company is committed to solving the critical challenges inherent in medication management and elevating the role of clinicians within healthcare as an essential component of care delivery.
The company’s major products and related services are medication management solutions and adherence tools for healthcare systems and pharmacies, which are sold in its principal market, the healthcare industry. The company’s market is primarily located in the United States.
Omnicell is focused on helping its customers define and deliver a medication management strategy designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. The company is doing this with an industry-leading medication management infrastructure, which includes robotics and smart devices, software workflows, expert services, and operational and optimization analytics. This comprehensive set of solutions provides the critical foundation for customers to realize the Autonomous Pharmacy, an industry-wide vision defined by pharmacy leaders for improving operational efficiencies and ultimately targeting zero-error medication management.
Business Strategy
The company focuses on delivering solutions to its customers realize the industry vision of the Autonomous Pharmacy and drive positive medication management outcomes with outstanding customer experience through a mature channel in four market categories: Point of Care, Central Pharmacy and IV Compounding, Specialty Pharmacy and 340B Program, and Ambulatory Care.
Products and Services
The company’s products and services span the evolving continuum of care, including inpatient, outpatient, and retail settings. The company provides a range of points of care medication and supply dispensing systems, including automated systems. The company also offers advanced automation solutions including robotics designed to automate work, streamline workflows, and reduce human error. Across these settings, the company provides central pharmacy automation solutions for both medication dispensing and IV compounding. The company also provides patient engagement solutions to help improve adherence to prescriptions. With certain automation and technology-enabled service offerings, the company provides expert services designed to help optimize utilization through subscription agreements, inclusive of expert personnel to operate the equipment. The company’s offerings include:
Points of Care
The company’s automation solutions for points of care are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. Automated dispensing systems are an essential part of medication management because they are designed to safeguard medications, including controlled substances, and provide automation to track inventory. The company strives to continually innovate its automated dispensing systems by designing features that are intended to help its customers close gaps in safety and enable clinicians to spend less time managing medications and more time caring for patients.
The company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. The company’s Points of Care Service combines market-leading automation, software workflows, expert services, and operational and optimization analytics to improve solution adoption and optimization, enhance data-driven performance, and drive nursing and pharmacy efficiency. The company also offers specialized automated dispensing systems. The company’s interoperability solutions enable integration of its automated dispensing systems with key electronic health record systems to streamline workflow and increase accuracy.
The company’s XT Amplify program is intended as a way for health systems to continue to introduce innovation even when challenged economically or operationally. This multi-year innovation program is designed to maximize value for hospitals, health systems, and post-acute care facilities that has already invested in Omnicell’s XT Series automated dispensing system and are seeking to enhance the capabilities of these devices in an effort to improve clinical and operational outcomes even further.
Specialty Pharmacy and 340B
The company’s Specialty Pharmacy Services offering provides a turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy. This solution is delivered through a risk-share commercial model and is intended for health systems, federally qualified health centers, and provider groups to support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. This offering is designed to drive specialty growth and cost savings, improve access to limited distribution drugs, and increase physician utilization for targeted disease states.
Inventory Optimization
The company’s Inventory Optimization Service provides predictive and prescriptive analytics, robust benchmarking, workflow tools, and expert clinical resources to help pharmacy staff quickly pinpoint and address potential inventory issues and optimization opportunities. The company’s Inventory Optimization Service is designed to provide greater medication inventory visibility, as well as reduce medication waste and expirations, stockouts, and shortages.
Patient Engagement, Clinical and Financial Solutions
The company’s EnlivenHealth brand extends beyond the inpatient setting and into ambulatory care. This brand offers a portfolio of products designed to digitally enable retail and community pharmacies with connected patient engagement and clinical and financial workflows intended to elevate the patient-pharmacy experience and enhance financial performance.
The company’s patient engagement solutions are designed to better educate, inform, and enrich patients’ lives through personalized interactive voice response, outbound communications, and mobile app offerings. The company also enables digital delivery of medication information (medication guides, vaccine information sheets, and drug monographs) to unlock patient preferences, staff efficiency, and environmental value. Additionally, the company’s clinical workflows help enable pharmacies to accelerate health and wellness in their community through targeted patient interventions, appointment scheduling, immunization, medication therapy management, medication synchronization, and Medicare plan comparisons.
Medication Adherence
The company’s medication adherence solutions, which include consumables and medication packaging systems, are designed to improve pharmacy operations and patient adherence to prescriptions. These solutions are used by institutional pharmacies serving long-term care and other non-acute healthcare facilities, as well as retail, community, and outpatient pharmacies.
The company’s single-dose automation solutions allow customers to fill and label a variety of patient-specific, single-dose medication blister packages based on incoming prescriptions. The company’s fully automated and semi-automated filling equipment is designed specifically for institutional pharmacies with enough order volume to warrant automated packaging of medications. The company’s automated solutions interface with pharmacy information systems to obtain prescription information.
For multi-medication prescriptions, the company offers software that guides users through the manual filling process to help streamline workflow with a goal of increased packaging accuracy. In addition, the company offers a wide range of medication blister card packaging and packaging supplies designed to enhance medication adherence in a variety of non-acute care settings.
Professional, Technical, and Customer Success Services
The company’s Professional Services offerings for health system pharmacies include technology installation, program management, customer education and training, change management services, and related offerings. The company’s customers as partners in the pursuit of better health outcomes for patients and improved satisfaction for the clinicians who serve them.
After Omnicell solutions are implemented, the company’s Customer Success team provides support through remote and onsite experts who help customers fully adopt and optimize utilization of its solutions.
The company’s technical services include post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades. Product support is available through fixed-period service contracts and on a time-and-materials basis. Onsite service is provided by the company’s field service team.
Retail Pharmacy and Hospital Automation Outside the United States
Additional products sold outside the United States include automated dispensing systems used in hospitals and retail pharmacies for handling the stocking and retrieval of boxed medications. For management of medical supplies, a specialized cabinet that uses radio frequency identification is also available, which is designed to improve picking and restocking workflows for nurses and surgeons.
Solutions
The company offers specialized services and analytics software designed to help healthcare facilities improve their bottom line and patient care by harnessing data from automation and other systems.
Sales and Distribution
The company sells its products and services primarily in the United States. Approximately 91% of the company’s revenue was generated in this market for the year ended December 31, 2024. The company’s sales force is organized by customer segment in the United States and Canada, with strategic and key account managers assigned to its top health systems; account executives, assigned to smaller health systems and healthcare facilities; and health system executives and solution experts focused on generating new business. The company’s sales in the United States and Canada are primarily made direct to end-user customers with the exception of some distribution of medication adherence consumables and automation in parts of Canada.
Outside of the United States and Canada, the company has direct sales employees in the United Kingdom, France, Germany, and Australia. For other geographies, such as the Middle East, Asia, and Latin America, it sells through distributors. In addition, the company’s international team handles direct sales, installation, and service for hospital healthcare facilities in the United Kingdom, Germany, and France, and for community pharmacies in the United Kingdom, Germany, and Australia. Sales, installation, and service to healthcare facilities are handled through distribution partners in other parts of Europe, Asia, Australia, the Middle East, and Latin America. The company’s products are available in a variety of languages including Traditional Chinese, Simplified Chinese, Croatian, Dutch, French, German, Japanese, Korean, Swedish, and Spanish. multiple years with options to renew or extend for up to two years and some of which can be terminated by either party at any time. The company’s most significant GPO contracts include Vizient, Inc., Premier Inc., HealthTrust Purchasing Group, and Advocate Health Supply Chain Alliance. The company also has a Federal Supply Schedule contract with the Department of Veterans Affairs (the ‘GSA Contract’), allowing the Department of Veterans Affairs, the Department of Defense, and other federal government customers to purchases its products. The accounts receivable balances are with individual members of the GPOs and federal agencies that purchase under the GSA Contract, and therefore no significant concentration of credit risk exists.
The company offers multi-year, non-cancelable lease payment terms to assist healthcare organizations in purchasing its systems by reducing their cash flow requirements in a lease structure. The company sells a portion of its multi-year lease receivables to third-party leasing finance companies.
The company’s clinical and technical consulting team supports its sales force by working with the company’s customers to identify potential solutions intended to help them achieve their desired outcomes. The company’s Professional Services team assists customers with the implementation of its solutions, including configuring the company’s systems to address the specific needs of each individual customer. After the solutions are implemented, the company’s Customer Success team provides remote and onsite experts who help its customers fully adopt and optimize utilization of the company’s solutions to achieve their desired clinical and business outcomes.
The company offers telephone and web-based technical support and issue resolution through its U.S.-based technical support centers. The company’s support centers are staffed 24 hours a day, 365 days a year. The company has found that a majority of its customers’ service issues can be addressed by the company’s support engineers either by phone or with remote diagnostic tools. In addition, the company’s customers can enable access to allow it to remotely monitor system performance of certain products. Where applicable, this suite of support tools is designed to proactively monitor certain system statuses and can alert service personnel to potential problems to preempt system failure and reduce unplanned downtime. The company’s field engineers deliver on-site services for hardware-related issues and are deployed to customer sites based on solution expertise and geographic proximity to customers. Additional support to the company’s field services is provided by certified external partners as needed.
Government Regulation
The company’s customers also use its products or services to obtain and store their personal information, including protected health information (as defined by the Health Information Portability and Accountability Act of 1996 and its implementing regulations, collectively ‘HIPAA’), from their patients and customers and sometimes personal information of their employees. As a result, the company and its customers are subject to various laws and regulations related to privacy, data protection, and information security. In the United States, these include federal health information privacy and security laws (such as HIPAA), various state and federal privacy and security breach notification laws, consumer protection laws, and individual state laws addressing privacy and security of personal and health information. Internationally, various foreign jurisdictions in which the company operates, including the European Union (the ‘EU’), have established, or are developing, their own data privacy and security legal frameworks with which the company’s customers are subject to including, for example, the United Kingdom’s Data Protection Act 2018 (being the U.K.’s implementation of the General Data Protection Regulation), and the EU’s General Data Protection Regulation (the ‘GDPR’). The GDPR imposes accountability and transparency requirements, data protection requirements, reporting obligations, and transfer restrictions.
The company’s products and solutions are regulated by the FDA and require 510(k) clearance prior to commercialization and marketing. With respect to the company’s products and solutions, it manufactures and develops specifications for products classified as Class I and Class II medical devices, which are subject to FDA regulation and require compliance with certain FDA regulations and requirements, including the FDA Quality System Regulation, as well as FDA regulations for medical device reporting.
The company also has a Federal Supply Schedule contract with the Department of Veterans Affairs (the ‘GSA Contract’), allowing the Department of Veterans Affairs, the Department of Defense, and other federal government customers to purchases its products.
Compliance with the laws and regulations applicable to the company’s global operations requires sufficient resources to actively maintain various governance, risk, and compliance systems in several areas to enables it to keep abreast of the constantly evolving legal and regulatory landscape both in the United States and abroad. These areas include, without limitation, FDCA and FDA, Controlled Substances Act and DEA regulations, individual state boards of pharmacy regulations, and laws and regulations regarding quality, privacy, information governance and security, and environmental, health and safety.
History
The company was founded in 1992. It was incorporated in California in 1992 under the name of Omnicell Technologies, Inc. and reincorporated in Delaware in 2001 as Omnicell, Inc.
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
